High-Dose Insulin for Hyperkalemic Cardiac Arrest.
| Autor: | Shikhooun MA; Department of Anesthesia, El Galaa Military Medical Complex, El-Orouba, Sheraton Al Matar, El Nozha, Cairo Governorate, Egypt., Abdulhadi LA; Intensive Care, National Heart Institute, Agouza, Giza Governorate, Egypt., Yafes WM; Cardiothoracic Surgery Department, El Galaa Military Medical Complex, El-Orouba, Sheraton Al Matar, El Nozha, Cairo Governorate, Egypt., Saleh MR; Intensive Care, Mahalla Cardiac Center, El Mahalla El Kobra, El Gharbeya, Egypt., Corsentino SA; Cardiovascular Surgery, Robert Wood Johnson University Hospital, New Brunswick, NJ; and., Pantin EJ; Department of Anesthesiology and Perioperative Medicine, Robert Wood Johnson University Hospital, New Brunswick, NJ. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | American journal of therapeutics [Am J Ther] 2023 Sep-Oct 01; Vol. 30 (5), pp. e426-e432. Date of Electronic Publication: 2022 Dec 26. |
| DOI: | 10.1097/MJT.0000000000001571 |
| Abstrakt: | Abstract: Hyperkalemic cardiac arrest diagnosis can be elusive and management difficult as the cardiac rhythm restoration is often not achieved until the potassium level decreases to a relatively normal level for the patient who suffers the arrest. Current treatment modalities can take hours to achieve this goal. We describe two patients who survived a witnessed hyperkalemic cardiac arrest after being managed with conventional advanced cardiac life support and unconventionally high doses of intravenous insulin. Competing Interests: The authors have no conflicts of interest to declare. (Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|